Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00298987
Status:
COMPLETED
Last Update Posted:
2010-02-08
First Post:
2006-03-02
Brief Title:
A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Organization Data
Organization:
Bristol-Myers Squibb
Class:
INDUSTRY
Study ID:
CA180-033
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bristol-Myers Squibb
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None